BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6167582)

  • 1. Complete primary structure of human C4a anaphylatoxin.
    Moon KE; Gorski JP; Hugli TE
    J Biol Chem; 1981 Aug; 256(16):8685-92. PubMed ID: 6167582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of human C4a anaphylatoxin.
    Gorski JP; Hugli TE; Müller-Eberhard HJ
    J Biol Chem; 1981 Mar; 256(6):2707-11. PubMed ID: 6970745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of the C4a anaphylatoxin from rat.
    Cui L; Ferreri K; Hugli TE
    Mol Immunol; 1988 Jul; 25(7):663-71. PubMed ID: 3262196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C4a: the third anaphylatoxin of the human complement system.
    Gorski JP; Hugli TE; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5299-302. PubMed ID: 291947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The isolation and characterization of bovine C4a, an activation fragment of the fourth component of complement.
    Booth NA; Campbell RD; Smith MA; Fothergill JE
    Biochem J; 1979 Dec; 183(3):573-8. PubMed ID: 540031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The active site of human C4a anaphylatoxin.
    Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
    Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative structural anatomy of the complement anaphylatoxin proteins C3a, C4a and C5a.
    Greer J
    Enzyme; 1986; 36(1-2):150-63. PubMed ID: 3491754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary structure of bovine complement activation fragment C4a, the third anaphylatoxin. Purification and complete amino acid sequence.
    Smith MA; Gerrie LM; Dunbar B; Fothergill JE
    Biochem J; 1982 Nov; 207(2):253-60. PubMed ID: 6760852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemistry and biology of anaphylatoxins.
    Hugli TE
    Complement; 1986; 3(3):111-27. PubMed ID: 3542363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and function of the anaphylatoxins.
    Hugli TE
    Springer Semin Immunopathol; 1984; 7(2-3):193-219. PubMed ID: 6387982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.
    Wagner JL; Hugli TE
    Anal Biochem; 1984 Jan; 136(1):75-88. PubMed ID: 6711816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human anaphylatoxin (C3a) from the third component of complement. Primary structure.
    Hugli TE
    J Biol Chem; 1975 Nov; 250(21):8293-301. PubMed ID: 1238393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
    Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ; Sumner H
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4.
    Blanchong CA; Chung EK; Rupert KL; Yang Y; Yang Z; Zhou B; Moulds JM; Yu CY
    Int Immunopharmacol; 2001 Mar; 1(3):365-92. PubMed ID: 11367523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of three separate anaphylatoxins from complement-activated human serum.
    Hugli TE; Gerard C; Kawahara M; Scheetz ME; Barton R; Briggs S; Koppel G; Russell S
    Mol Cell Biochem; 1981 Dec; 41():59-66. PubMed ID: 6977086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
    Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylatoxin levels in human vitreous humor.
    Mondino BJ; Sidikaro Y; Sumner H
    Invest Ophthalmol Vis Sci; 1988 Jul; 29(7):1195-8. PubMed ID: 3262096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
    Takematsu H; Ohkohchi K; Tagami H
    Br J Dermatol; 1986 Jan; 114(1):1-6. PubMed ID: 3484631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.